Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Oracle (ORCL) PT Raised to $271 at Cantor Fitzgerald
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $290 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Scholar Rock (SRRK) at Overweight
-
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
-
Cantor Fitzgerald Reiterates Overweight Rating on HubSpot Inc (HUBS)
-
Microsoft (MSFT) PT Raised to $581 at Cantor Fitzgerald
-
ServiceNow (NOW) PT Raised to $1,200 at Cantor Fitzgerald
-
Alphabet (GOOGL) PT Raised to $196 at Cantor Fitzgerald
-
Amazon.com (AMZN) PT Raised to $260 at Cantor Fitzgerald
-
Meta Platforms Inc. (META) PT Raised to $828 at Cantor Fitzgerald
-
Fortinet (FTNT) PT Raised to $110 at Cantor Fitzgerald
-
Checkpoint Software (CHKP) PT Raised to $230 at Cantor Fitzgerald
-
ESGold's (ESAU) (ESAUF) Gold-Silver Project - Risk-Off in a Risky Industry
-
Gold Reserve Announces up to US$20.0 Million Brokered Private Placement of Common Shares
-
Datadog (DDOG) PT Raised to $171 at Cantor Fitzgerald
-
H.C. Wainwright Appoints Mark E. Kaplan as Chief Executive Officer; Mark Viklund Named Executive Vice Chairman of the Board
-
Cantor Fitzgerald Reiterates Overweight Rating on Oranogenesis Holdings (ORGO)
-
Cantor Fitzgerald Reiterates Overweight Rating on MiMedx Group (MDXG)
-
Cantor Fitzgerald Reiterates Overweight Rating on AIRO Group (AIRO)
-
Cantor Fitzgerald Reiterates Overweight Rating on AeroVironment (AVAV)
-
Cantor Fitzgerald Reiterates Overweight Rating on Kratos Defense & Security (KTOS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Redwire (RDW)
-
Cantor Fitzgerald Reiterates Overweight Rating on Sanara MedTech (SMTI)
-
Cantor Fitzgerald Starts Oklo (OKLO) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Coinbase Global Inc. (COIN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)
-
Cantor Fitzgerald Reiterates Overweight Rating on VinFast Auto Ltd. (VFS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Polestar Automotive Holding Uk Plc (PSNY)
-
Cantor Fitzgerald Reiterates Neutral Rating on Lucid Group Inc. (LCID)
-
Cantor Fitzgerald Reiterates Neutral Rating on Rivian Automotive Inc (RIVN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
Cantor Fitzgerald Reiterates Overweight Rating on TruBridge Inc (TBRG)
-
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT)
-
Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Almonty prices $90 million public offering, lists on NASDAQ
-
Almonty Announces Nasdaq Listing Concurrent with Pricing of US$90 Million Upsized, Oversubscribed Public Offering
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
Cantor Fitzgerald Reiterates Overweight Rating on WAVE Life Sciences (WVE)
-
Cantor Fitzgerald Starts Tvardi Therapeutics Inc (TVRD) at Overweight
-
Cantor Fitzgerald Starts Harrow Health (HROW) at Overweight
-
Cantor Fitzgerald Starts Inova Technology, Inc. (INVA) at Overweight
-
Cantor Equity Partners, Inc. and Twenty One Capital, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
-
Soleno Therapeutics prices $200 million stock offering at $85 per share
-
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on HubSpot Inc (HUBS)
-
Cantor Fitzgerald Reiterates Overweight Rating on salesforce.com (CRM)
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $29 at Cantor Fitzgerald
-
Cantor Fitzgerald Raises Price Target on Bitdeer Technologies Group (BTDR) to $23
-
Cantor Fitzgerald Reiterates Overweight Rating on Eledon Pharamceuticals (ELDN)
-
Cantor Fitzgerald Reiterates Neutral Rating on Merck (MRK)
-
Cantor Fitzgerald Reiterates Overweight Rating on Apellis Pharmaceuticals (APLS)

